26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

asophil 102 Bcl-2 family<br />

A peripheral blood basophil showing a bilobed nucleus and cytoplasmic<br />

granules that represent storage sites of pharmacological mediators of<br />

immediate type I hypersensitivity.<br />

Neutrophil and basophil in peripheral blood.<br />

basophil<br />

A polymorphonuclear leukocyte of myeloid lineage with<br />

distinctive basophilic secondary granules in the cytoplasm<br />

that frequently overlie the nucleus. These granules are<br />

storage depots for heparin, histamine, platelet-activating<br />

factor, and other pharmacological mediators of immediate<br />

hypersensitivity. Degranulation of the cells with release<br />

of these pharmacological mediators takes place following<br />

crosslinking by allergens or antigens of Fab regions<br />

of IgE receptor molecules bound through Fc receptors to<br />

cell surfaces. They comprise less than 0.5% of peripheral<br />

blood leukocytes. Following crosslinking of surface-bound<br />

IgE molecules by specific allergen or antigen, granules<br />

are released by exocytosis. Substances liberated from the<br />

granules are pharmacological mediators of immediate (type<br />

I) anaphylactic hypersensitivity.<br />

basophil-derived kallikrein (BK-A)<br />

BK-A represents the only known instance in which an activator<br />

of the kinin system is generated directly from a primary<br />

immune reaction. The molecule is a high molecular<br />

weight enzyme with arginine esterase activity. It is stored in<br />

the producing cells in a preformed state. Its release depends<br />

on basophil–IgE interactions with antigen and parallels the<br />

release of histamine.<br />

basophilic<br />

An affinity of cells or tissues for basic stains leading to a<br />

bluish tint.<br />

BCDF<br />

Abbreviation for B cell differentiation factor.<br />

BCG (bacille Calmette–Guérin)<br />

A Mycobacterium bovis strain maintained for more than<br />

75 years on potato, bile, glycerine agar that preserves<br />

the immunogenicity but dissipates the virulence of the<br />

microorganism. It has long been used in Europe as a<br />

vaccine against tuberculosis, although it never gained<br />

popularity in the United States. It has also been used in<br />

tumor immunotherapy to nonspecifically activate immune<br />

responses in selected tumor-bearing patients, such as those<br />

with melanoma or bladder cancer. It has been suggested as<br />

a possible vector for genes that determine human immunodeficiency<br />

virus (HIV) proteins such as gag, pol, env,<br />

gp20, gp40, reverse transcriptase, and tetanus toxin. In<br />

certain countries with high incidences of tuberculosis,<br />

BCG provides effective immunity against the disease,<br />

diminishing the risk of infection by approximately 75%.<br />

The vaccine has the disadvantage of rendering skin testing<br />

for tuberculosis inaccurate, especially in the first 5 years<br />

after inoculation, because it induces hypersensitivity to<br />

tuberculin. Intended for protection against tuberculosis in<br />

individuals not previously infected with Mycobacterium<br />

tuberculosis who are at high risk for exposure. Designed<br />

for percutaneous use as an attenuated live culture preparation<br />

of the Bacillus of Calmette and Guerin (BCG)<br />

strain of M. bovis. The TICE strain was developed at<br />

the University of Illinois from a strain originated at the<br />

Institut Pasteur in Paris.<br />

BCGF (B cell growth factor)<br />

See interleukins 4, 5, and 6.<br />

BCG vaccine<br />

Refer to BCG (bacille Calmette-Guérin).<br />

Bcl-2<br />

A 25-kDa human oncoprotein that is believed to play a<br />

regulatory role in tissue development and maintenance in<br />

higher organisms by preventing the apoptosis of specific<br />

cell types. The inhibitory effect of Bcl-2 is influenced by<br />

the expression of other gene products such as bax, bcl-xs,<br />

bak, and bad that promote apoptosis. Bcl-2 is situated at the<br />

outer membranes of mitochondria, the endoplasmic reticulum,<br />

and the nuclear membrane and may prevent apoptosis<br />

either by acting at these locations or as an antioxidant<br />

that neutralizes the effects of reactive oxygen species that<br />

promote apoptosis or by obstructing mitochondrial channel<br />

openings, thereby preventing the release of factors that promote<br />

apoptosis. Bcl-2 is involved in the development of the<br />

adult immune system as demonstrated by studies with Bcl-2<br />

knockout mice. Failure to induce normal levels of apoptosis<br />

due to overexpression of Bcl-2 may contribute to the development<br />

of lymphoproliferative disorders and acceleration<br />

of autoimmunity under the appropriate genetic background.<br />

The role of Bcl-2 in human systemic lupus erythematosus<br />

(SLE) and PSS has not yet been fully defined.<br />

Bcl-2 family<br />

The Bcl-2 family consists of proteins that share homology<br />

to Bcl-2 in one or more of the Bcl-2 homology regions<br />

designated BH1, BH2, BH3, and BH4. Many of the family<br />

members have carboxyl-terminal mitochondrial membrane<br />

targeting sequences. All have two central membrane-spanning<br />

helices surrounded by additional amphipathic helices.<br />

X-ray crystallographic studies have shown that Bcl-x L<br />

has structural similarity to diphtheria toxin and colicins.<br />

Diphtheria toxin is endocytosed by cells. Acidification of

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!